U.S. markets close in 2 hours 42 minutes
  • S&P 500

    3,445.01
    +1.89 (+0.05%)
     
  • Dow 30

    28,286.64
    -22.15 (-0.08%)
     
  • Nasdaq

    11,513.79
    -2.70 (-0.02%)
     
  • Russell 2000

    1,607.99
    -9.71 (-0.60%)
     
  • Crude Oil

    39.92
    -1.78 (-4.27%)
     
  • Gold

    1,927.60
    +12.20 (+0.64%)
     
  • Silver

    25.23
    +0.25 (+0.98%)
     
  • EUR/USD

    1.1876
    +0.0048 (+0.40%)
     
  • 10-Yr Bond

    0.8040
    +0.0070 (+0.88%)
     
  • GBP/USD

    1.3157
    +0.0210 (+1.62%)
     
  • USD/JPY

    104.4840
    -0.9860 (-0.93%)
     
  • BTC-USD

    12,840.57
    +1,783.56 (+16.13%)
     
  • CMC Crypto 200

    257.32
    +12.43 (+5.07%)
     
  • FTSE 100

    5,776.50
    -112.72 (-1.91%)
     
  • Nikkei 225

    23,639.46
    +72.42 (+0.31%)
     

EIDX INVESTIGATION - Shareholder Rights Firm Labaton Sucharow is Investigating Eidos Therapeutics (NASDAQ:EIDX) for Potential Securities Violations and Breach of Fiduciary Duty

·1 min read

NEW YORK, NY / ACCESSWIRE / October 8, 2020 / Labaton Sucharow, a nationally ranked shareholder rights firm, is investigating potential securities violations and breach of fiduciary duty claims against clinical-stage biotech company Eidos Therapeutics. (NASDAQ:EIDX).

If you currently own shares of Eidos and want to receive additional information and protect your investments free of charge, please contact David J. Schwartz using the toll free number (800) 321-0476 or via email at dschwartz@labaton.com.

About the Firm

Labaton Sucharow LLP is one of the world's leading complex litigation firms representing clients in securities, antitrust, corporate governance and shareholder rights, and consumer cybersecurity and data privacy litigation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at http://www.labaton.com.

Contact:

David J. Schwartz
(800) 321-0476
dschwartz@labaton.com

SOURCE: Labaton Sucharow LLP



View source version on accesswire.com:
https://www.accesswire.com/609658/EIDX-INVESTIGATION--Shareholder-Rights-Firm-Labaton-Sucharow-is-Investigating-Eidos-Therapeutics-NASDAQEIDX-for-Potential-Securities-Violations-and-Breach-of-Fiduciary-Duty